VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $984,000 | -25.0% | 42,350 | -48.6% | 0.46% | -25.4% |
| Q1 2018 | $1,312,000 | +465.5% | 82,416 | +6239.7% | 0.62% | +558.5% |
| Q3 2015 | $232,000 | -19.7% | 1,300 | 0.0% | 0.09% | +1.1% |
| Q2 2015 | $289,000 | -36.8% | 1,300 | -43.5% | 0.09% | -16.2% |
| Q1 2015 | $457,000 | +62.1% | 2,300 | -4.2% | 0.11% | +362.5% |
| Q4 2013 | $282,000 | -50.0% | 2,400 | -55.6% | 0.02% | -44.2% |
| Q3 2013 | $564,000 | +21.0% | 5,410 | 0.0% | 0.04% | +10.3% |
| Q2 2013 | $466,000 | -87.0% | 5,410 | -88.7% | 0.04% | -84.5% |
| Q1 2013 | $3,577,000 | +264.3% | 47,680 | +152.3% | 0.25% | +445.7% |
| Q2 2011 | $982,000 | – | 18,900 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |